Abstract
Ovarian cancer (OV) is one of the most lethal gynecological malignance in females, and usually diagnosed at advanced stages. Long noncoding RNAs (lncRNAs) exhibit their crucial functions in modulatory mechanisms of cancers. Substantive studies have proven the anti-tumor role of MAGI2-AS3 in multiple cancers, but the physiological functions of MAGI2-AS3 in OV need more detailed explanations. The current study corroborated that overexpression of MAGI2-AS3 executed inhibitory activity in OV via hindering cell proliferation, cell cycle, migration as well as invasion while promoted apoptosis. Moreover MAGI2-AS3 bound with miR-525-5p and negatively regulated the expression of miR-525-5p. Further studies testified that MXD1 was a downstream target of miR-525-5p and the competing relationship between MAGI2-AS3 and MXD1 were confirmed by RNA pull down. Based on the combination between MAX and MYC, we analyzed the effects of MAGI2-AS3 on MXD1 and MYC, unveiling the competing relationship between MXD1 and MYC for binding to MAX. Finally, we constructed rescue assays to certify that MAGI2-AS3 suppressed the course of OV via enhancing MXD1 expression. In summary, MAGI2-AS3 repressed the progression of OV by targeting miR-525-5p/MXD1 axis, o...Continue Reading
References
Mar 13, 2014·The Journal of Clinical Investigation·Yuanzhi LuXianghong Zou
Jan 22, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dong-Liang ChengXiao-Jie Lu
May 16, 2015·Molecular Medicine Reports·Juan XiaoJundong Li
Aug 21, 2015·Journal of Neuro-oncology·Anna M DahlinBeatrice Melin
Nov 10, 2015·Future Oncology·Katrina K AuMadhuri Koti
Feb 2, 2016·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Lijun Dong, Lina Hui
Aug 28, 2016·Neoplasma·A ZouX Wu
Sep 3, 2016·Oncology Letters·Wenxia HuWei Liu
Sep 14, 2016·Annals of Family Medicine·J LeBron McBride
May 20, 2017·Experimental & Molecular Medicine·Hye Youn SungJung-Hyuck Ahn
May 28, 2017·Oncology Research·Fu HuaXiao-Ping Liu
Jul 30, 2017·Experimental Cell Research·Yuan CaoRuitao Zhang
Oct 12, 2017·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·Myriam KossaïCatherine Genestie
Dec 13, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E Pujade-Lauraine
Apr 10, 2018·Obstetrics and Gynecology·Usha MenonAleksandra Gentry-Maharaj
Apr 22, 2018·Human Cell·Yong YangKui Liu
Jun 22, 2018·The Journal of Pathology·Jin-Fen XiaoH Phillip Koeffler
Aug 3, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Xinfeng LiuHao Song
Aug 16, 2018·Biochemical and Biophysical Research Communications·He YuGuangxin Liu
Oct 20, 2018·Neoplasma·F ChenX Zheng
Nov 18, 2018·Biochemical and Biophysical Research Communications·Feng WangGonghui Li
Nov 18, 2018·Biochemical and Biophysical Research Communications·Wenling DuQinqin Sun
Mar 19, 2019·Cancer Biomarkers : Section a of Disease Markers·Shanmei DuKui Liu
Aug 16, 2019·Journal of Experimental & Clinical Cancer Research : CR·Huan YanChenchen Ren
Oct 23, 2019·The Journal of Surgical Research·Xiliang ZhangChaojun Zhang
Dec 4, 2019·Aging·Weiyang LouPeifen Fu
Feb 14, 2020·FEBS Letters·Mark J DemmaJennifer O'Neil
Citations
Sep 25, 2020·Cancers·Naiade CalancaSilvia Regina Rogatto
Nov 29, 2020·Journal of Clinical Laboratory Analysis·Yingchun LiYanfei Li
Nov 27, 2020·International Journal of Molecular Sciences·Eleonora A BragaNikolay E Kushlinskii
Jan 26, 2021·OncoTargets and Therapy·Miao DaShuwen Han
Mar 16, 2021·Frontiers in Oncology·Jeyshka M Reyes-González, Pablo E Vivas-Mejía
Mar 26, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Chen XueJunjun Jia
Jun 15, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Liu Kai-XinXu Peng
Oct 9, 2021·Frontiers in Oncology·Kai ZhangKangwu Chen